Some sources regard clotiapine as a [[typical antipsychotic]] rather than [[Atypical antipsychotic|atypical]] due to its high incidence of [[extrapyramidal side effects]] compared to the atypicals like [[clozapine]] and [[quetiapine]], to which it is structurally related.<ref name = ClotChlor>{{cite journal|title=Clotiapine compared with chlorpromazine in chronic schizophrenia|journal=Schizophrenia Research|volume=80|issue=2–3|pages=343–347|author1=Geller, V |author2=Gorzaltsan, I |author3=Shleifer, T |author4=Belmaker, RH |author5=Bersudsky, Y |pmid=16126373|date=December 2005|doi=10.1016/j.schres.2005.07.007}}</ref> Despite its profile of a relatively high incidence of extrapyramidal side effects it has demonstrated efficacy in treatment-resistant individuals with schizophrenia according to a number of psychiatrists with clinical experience with it, some weak clinical evidence supports this view too.<ref name = forg>{{cite journal|title=Clotiapine: Another forgotten treasure in psychiatry?|journal=European Neuropsychopharmacology|volume=7|issue=Suppl 2|pages=S217|doi=10.1016/S0924-977X(97)88712-3|date=September 1997|author1=Lokshin, P |author2=Kotler, M |author3=Belmaker, RH }}</ref><ref name = ClotChlor/><ref>{{cite journal|title=chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients|journal=South African Medical Journal|date=August 1971|volume=45|issue=34|pages=945–947|pmid=4939661|url=http://archive.samj.org.za/1971%20VOL%20XLV%20Jul-Dec/Articles/08%20August/4.3%20CHLORPROMOZAINE,%20CLOTIAPINE%20AND%20THIORIDAZINE%20-%20A%20COMPARATIVE%20CLINICAL%20TRIAL%20AND%20BANTU%20PSYCHOT.pdf|format=PDF|author1=Van Wyk, AJ |author2=Marais, GF }}</ref> A [[systematic review]] compared clotiapine with other antipsychotic drugs: 

 
! colspan="4" style="text-align: left;"| [[Adverse event|Adverse effects]]
